echoloc
Company profile

Mirum Pharmaceuticals, Inc. Tech Stack

Rare disease biopharma commercializing liver and metabolic therapies

Pharmaceutical Manufacturing Foster City, CA 201–500 employees Founded 2018 Public Company

Mirum Pharmaceuticals markets rare disease medicines, including LIVMARLI, CHOLBAM and CTEXLI, while advancing late-stage liver disease candidates. Hiring is accelerating and overwhelmingly sales-led, with field teams focused on closing patient identification and diagnosis gaps. The stack pairs Veeva, Salesforce and Komodo for commercial targeting with Snowflake, Power BI and Tableau for analytics, and the company is adopting DocuSign CLM and Agiloft to formalize contract management.

Tech Stack 26 technologies

Core StackSnowflake Power BI Tableau DocuSign Salesforce SAS Intune Okta Zoom Greenhouse Concur Veeva Electronic Data Capture Komodo Adaptive Planning CDISC Adobe Box Veeva QMS VBA LC-MS/MS Veeva Systems PubMed EndNote
AdoptingSalesforce DocuSign CLM Agiloft

What Mirum Pharmaceuticals, Inc. Is BuildingChallenges and projects from their job posts

◆Challenges

  • Patient identification and diagnosis gaps in rare disease
  • Patient access barriers across complex care journeys
  • Identifying high-opportunity customers
  • Overcoming clinical inertia among prescribers
  • Consistent commercial execution across regions

▲Active Projects

  • Implementation of Veeva Vault QMS modules
  • Territory and regional business plan development
  • Strategic account plans for priority treatment centers
  • Establishing referral pathways and closing diagnostic gaps
  • Named patient programs
  • Regulatory advertising and promotional review processes

Hiring Activity

Accelerating65 roles · 30 in 30d

Department

Sales
47
Legal
5
Healthcare
4
Marketing
3
Ops
2
Engineering
1
Manufacturing
1
Operations
1

Seniority

Mid
27
Senior
19
Director
16
VP
3
Manager
2

Notable leadership hires: Regional Business Director, Scientific Director, Director IT

Companies like Mirum Pharmaceuticals, Inc.

200+ Pharmaceutical Manufacturing companies running Power BI and Tableau

See the full list

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals is a public rare disease company headquartered in Foster City, CA, founded in 2018, with 201–500 employees. Its approved products are LIVMARLI (maralixibat) for Alagille syndrome and PFIC, CHOLBAM (cholic acid) for bile-acid synthesis disorders, and CTEXLI (chenodiol) for cerebrotendinous xanthomatosis. The clinical pipeline includes volixibat for PSC and PBC, brelovitug for chronic hepatitis delta virus, and MRM-3379 for Fragile X syndrome. The company sells to specialist treatment centers and hires across the United States, Switzerland, Italy and Germany.

HeadquartersFoster City, CA
Company Size201–500 employees
Founded2018
Hiring MarketsUnited States, Switzerland, Italy, Germany

Frequently Asked Questions

What tech stack does Mirum Pharmaceuticals use?

Mirum uses Veeva, Veeva QMS, Salesforce, Komodo, Snowflake, Power BI, Tableau, SAS, CDISC, Electronic Data Capture, Adaptive Planning, Concur, Okta, Intune, Box and Greenhouse, and is adopting DocuSign CLM and Agiloft.

Is Mirum Pharmaceuticals hiring sales reps?

Yes. Hiring is accelerating and heavily sales-focused, including Regional Business Director roles, with smaller openings in legal, marketing and healthcare functions.

What countries does Mirum Pharmaceuticals hire in?

Mirum is hiring in the United States, Switzerland, Italy and Germany, with headquarters in Foster City, California.

Similar Companies in Pharmaceutical Manufacturing

Other companies in the same industry, closest in size

How this profile is built

Mirum Pharmaceuticals, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.